To compare the effects of pelacarsen (TQJ230) 80 mg Q4W vs placebo on the rate of lipoprotein apheresis

(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.